HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.

Abstract
Most cases of frontotemporal lobar degeneration (FTLD) are characterized by the abnormal accumulation of either the microtubule-associated protein tau or the transactive response DNA-binding protein with M(r) 43 kDa, TDP-43 (FTLD-tau and FTLD-TDP, respectively). However, there remain ∼10% of cases, composed of a heterogenous collection of uncommon disorders, for which the molecular basis remains uncertain. In this review, we describe the characteristic genetic, clinical, and pathological features of the major tau/TDP-negative FTLD subtypes, with focus on recent advances in our understanding of their molecular basis. This includes the discovery that the pathological changes in atypical FTLD with ubiquitinated inclusions, neuronal intermediate filament inclusion disease, and basophilic inclusion body disease are immunoreactive for the fused in sarcoma (FUS) protein, resulting in the creation of a new molecular subgroup (FTLD-FUS), and studies clarifying the functional consequences of pathogenic CHMP2B mutations.
AuthorsIan R A Mackenzie, Manuela Neumann, Nigel J Cairns, David G Munoz, Adrian M Isaacs
JournalJournal of molecular neuroscience : MN (J Mol Neurosci) Vol. 45 Issue 3 Pg. 402-8 (Nov 2011) ISSN: 1559-1166 [Electronic] United States
PMID21603977 (Publication Type: Journal Article, Review)
Chemical References
  • CHMP2B protein, human
  • DNA-Binding Proteins
  • Endosomal Sorting Complexes Required for Transport
  • RNA-Binding Protein FUS
  • Ubiquitin
  • tau Proteins
Topics
  • Brain (metabolism, pathology)
  • Chromosomes, Human, Pair 3
  • DNA-Binding Proteins (genetics, metabolism)
  • Endosomal Sorting Complexes Required for Transport (genetics)
  • Frontotemporal Lobar Degeneration (classification, genetics, pathology, physiopathology)
  • Humans
  • Inclusion Bodies (chemistry, pathology)
  • Intermediate Filaments (metabolism, pathology)
  • Neurons (metabolism, pathology)
  • RNA-Binding Protein FUS (genetics, metabolism)
  • Ubiquitin (metabolism)
  • tau Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: